Roots-Analysis-Logo.png
The cell therapy manufacturing market is anticipated to grow at an annualized rate of over 12%, claims Roots Analysis
November 22, 2022 09:00 ET | Roots Analysis
London, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (5th Edition), 2022-2035” report to its list of offerings. Owing to the...
Roots-Analysis-Logo.png
The Manufacturing Execution System Providers in Healthcare market is projected to grow at a CAGR of 16%, till 2035, claims Roots Analysis
November 21, 2022 12:35 ET | Roots Analysis
London, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Manufacturing Execution System Providers in Healthcare Market, 2022-2035” report to its list of offerings. ...
Roots-Analysis-Logo.png
The opportunity within the cytotoxic drugs and HPAPI manufacturing market is projected to grow at an annualized rate of ~12%, till 2035, claims Roots Analysis
November 21, 2022 12:18 ET | Roots Analysis
London, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Cytotoxic Drugs and HPAPI Manufacturing Market (4th Edition), 2022 – 2035” report to its list of offerings. ...
Roots-Analysis-Logo.png
The biopharmaceutical contract manufacturing market is projected to grow at a CAGR of 10% during 2022-2035, claims Roots Analysis
November 01, 2022 13:20 ET | Roots Analysis
London, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Biopharmaceutical Contract Manufacturing Market, 2022–2035” report to its list of offerings. In pursuit...
Roots-Analysis-Logo.png
The gene therapy market is projected to be worth USD 17.3 billion in 2035, growing at a CAGR of 18%, during the period 2022-2035, claims Roots Analysis
July 27, 2022 10:00 ET | Roots Analysis
London, July 27, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Gene Therapy Market” report to its list of offerings. Post the emergence of blockbuster gene therapies, such...
Roots-Analysis-Logo.png
The top selling biologics market is projected to be worth USD 156 billion by 2030, claims Roots Analysis
October 20, 2021 09:00 ET | Roots Analysis
London, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Top Selling Biologics Market, 2021 – 2030” report to its list of offerings. Over the years, around 200...
Roots-Analysis-Logo.png
The pharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~7%, till 2030, claims Roots Analysis
October 07, 2021 08:40 ET | Roots Analysis
London, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Pharmaceutical Contract Manufacturing Market (3rd Edition), 2021-2030” report to its list of offerings. The...
Roots-Analysis-Logo.png
The cell therapy manufacturing market is projected to reach USD 14.5 billion by 2030, growing at an annualized rate of 18%, claims Roots Analysis
July 01, 2021 08:00 ET | Roots Analysis
London, July 01, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (4th Edition), 2021-2030” report to its list of offerings. Owing to the...
Roots-Analysis-Logo.png
The viral and non-viral vector manufacturing market is projected to grow at an annualized rate of over 15%, claims Roots Analysis
May 06, 2021 08:45 ET | Roots Analysis
London, May 06, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th Edition) 2021 – 2030” report to its...
Roots-Analysis-Logo.png
The gene therapy market is projected to be worth USD 14.6 billion in 2030, growing at a CAGR of 30%, over the next decade, claims Roots Analysis
February 02, 2021 11:19 ET | Roots Analysis
London, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Gene Therapy Market (4th Edition), 2020-2030” report to its list of offerings. Success of approved gene...